Moderna Inc (0QF.D.EB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [BXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,922,000 | 3,199,000 | 6,754,000 | 18,875,000 | 17,736,000 |
| Cost of Goods | 868,000 | 1,464,000 | 4,693,000 | 5,416,000 | 2,617,000 |
| Gross Profit | 1,054,000 | 1,735,000 | 2,061,000 | 13,459,000 | 15,119,000 |
| Operating Expenses | 4,128,000 | 5,680,000 | 6,300,000 | 4,039,000 | 1,823,000 |
| Operating Income | -3,074,000 | -3,945,000 | -4,239,000 | 9,420,000 | 13,296,000 |
| Interest Expense | 10,000 | 24,000 | 38,000 | 29,000 | 18,000 |
| Other Income | 316,000 | 362,000 | 335,000 | 184,000 | 7,000 |
| Pre-tax Income | -2,768,000 | -3,607,000 | -3,942,000 | 9,575,000 | 13,285,000 |
| Income Tax | 54,000 | -46,000 | 772,000 | 1,213,000 | 1,083,000 |
| Net Income Continuous | -2,822,000 | -3,561,000 | -4,714,000 | 8,362,000 | 12,202,000 |
| Net Income | $-2,822,000 | $-3,561,000 | $-4,714,000 | $8,362,000 | $12,202,000 |
| EPS Basic Total Ops | N/A | -9.28 | -12.33 | 21.26 | 30.31 |
| EPS Basic Continuous Ops | N/A | -9.28 | -12.33 | 21.26 | 30.31 |
| EPS Diluted Total Ops | N/A | -9.28 | -12.33 | 20.12 | 28.29 |
| EPS Diluted Continuous Ops | N/A | -9.28 | -12.33 | 20.12 | 28.29 |
| EBITDA(a) | $-2,543,000 | $-3,394,000 | $-3,283,000 | $9,952,000 | $13,535,000 |